re: Ann: FDA agrees on potential regulatory p... The usual wording that does not inspire confidence "potential regulatory path to progress OMAPRO"
and the timeline only for the patient: "we plan to submit our new NDA to the FDA by the end of the year" Seeing is believing
Ann: FDA agrees on potential regulatory pathway f, page-2
Add to My Watchlist
What is My Watchlist?